Closed |
S9704 |
NON-HODGKIN'S: CHOP x 8 vs. CHOP x 6 followed by TBI/VP-6/cylophosphamide or SWOG BCV with stem cell rescue |
9/15/1997 |
12/15/2007 |
100% |
|
Published
|
Closed |
S0016 |
NON-HODGKIN'S: CHOP/rituximab vs. CHOP/tositumomab |
3/1/2001 |
10/2/2008 |
100% |
|
Published
|
Closed |
SWOG-9438 |
NON-HODGKIN'S: Debulking salvage chemo adn stem cell harvest -> TBI/cyclophosphamide -> PBSCT and randmization to IL-2 or obs. |
5/15/1995 |
7/1/2004 |
98% |
|
Published
|
Closed |
S0019 |
NON-HODGKIN'S: ICE +/- Rituxan for Relapsed/Refractory CD20+ B-Cell NHL |
10/15/2000 |
12/15/2001 |
2% |
|
Published
|
Closed |
S0515 |
NON-HODGKIN'S: R-CHOP + Bevacizumab for Adv Stage Diffuse Large B-cell NHL |
6/15/2005 |
9/15/2008 |
100% |
|
Published
|
Closed |
S0350 |
NON-HODGKIN: PEGS treatment for Peripheral T-Cell NHL |
9/15/2005 |
12/1/2010 |
100% |
|
Published
|
Closed |
S0520 |
NON-HODGKIN: PXD101 Therapy for B-Cell Lymphoma |
1/1/2006 |
5/1/2009 |
55% |
|
Published
|
Closed |
S0433 |
NON-HODGKIN: R-CHOP + Bexxar for Advanced Stage Diffuse Large B-Cell Lymphoma |
11/1/2005 |
|
100% |
|
Published
|
Closed |
S0601 |
NON-HODGKINS: R-CHOP-V followed by VM maintenance therapy for MCL |
8/15/2006 |
6/1/2008 |
100% |
|
Published
|
Closed |
S0120 |
Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders |
6/1/2002 |
4/1/2011 |
97% |
|
Published
|
Closed |
S0341 |
OSI-774/PS 2/selected Stage IIIB or IV NSCLC |
9/15/2004 |
10/1/2005 |
100% |
|
Published
|
Closed |
S9701 |
OVARIAN |
11/15/1997 |
12/1/2001 |
62% |
|
Published
|
Closed |
S9912 |
OVARIAN |
10/1/2000 |
8/15/2005 |
100% |
|
Published
|
Closed |
S0009 |
OVARIAN |
3/15/2001 |
2/1/2006 |
100% |
|
Published
|
Closed |
S0211 |
Ovarian |
4/15/2002 |
1/1/2006 |
77% |
|
Published
|
Closed |
S0200 |
OVARIAN |
8/15/2002 |
12/15/2004 |
6% |
|
Published
|
Closed |
S9700 |
PANCREAS |
9/15/1997 |
6/19/2001 |
90% |
|
Published
|
Closed |
S9924 |
PANCREAS |
6/1/2000 |
6/1/2001 |
97% |
|
Published
|
Closed |
S0107 |
PANCREAS |
7/1/2001 |
6/1/2003 |
100% |
|
Published
|
Closed |
S0727 |
Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 |
3/1/2008 |
9/1/2010 |
100% |
|
Published
|